Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 464,370 | 250,314 | 83,803 | 22,813 | 61 |
| Cost of Goods | 33,745 | 20,443 | 8,035 | 1,895 | N/A |
| Gross Profit | 430,625 | 229,871 | 75,768 | 20,918 | 61 |
| Operating Expenses | 590,751 | 493,940 | 361,491 | 253,041 | 154,073 |
| Operating Income | -159,381 | -263,626 | -285,688 | -231,228 | -154,012 |
| Other Income | 20,343 | 7,376 | 1,568 | 4,236 | 6,291 |
| Pre-tax Income | -139,038 | -256,250 | -284,120 | -226,992 | -147,721 |
| Income Tax | 636 | 6 | 6 | 14 | 2 |
| Net Income Continuous | -139,674 | -256,256 | -284,126 | -227,006 | -147,722 |
| Net Income | $-139,674 | $-256,256 | $-284,126 | $-227,006 | $-147,722 |
| EPS Basic Total Ops | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 |
| EPS Basic Continuous Ops | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 |
| EPS Diluted Total Ops | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 |
| EPS Diluted Continuous Ops | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 |
| EPS Diluted Before Non-Recurring Items | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 |
| EBITDA(a) | $-167,253 | $-262,523 | $-289,235 | $-231,348 | $-154,666 |